Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Patrick Chew

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
corporate, debt facility, healthcare and life sciences
Office
New York
Active in the record
2024 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPODebt Capital MarketsJoint VentureM&AVenture Capital & Growth
Sectors
Financial ServicesHealthcare & Life SciencesTechnology
Jurisdictions
NasdaqUnited KingdomUnited States

Recent deals

24 announced deals in the record
Latham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLsLatham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLs 19 Oct 2026
Joint Venture Healthcare & Life Sciences Latham & Watkins LLP life sciences licensing
Latham Advises on Vaxcyte’s Concurrent Public Offerings of Common Stock, Pre-Funded Warrants, and Convertible Senior Notes 8 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 500m intellectual property
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering 28 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 446m intellectual property matters
Latham & Watkins Advises on Vaderis Therapeutics’ US$152 Million Series B Financing 24 Sept 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 152m intellectual property
Latham Advises on Satellos’ US$50 Million ATM Offering 18 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 50m IP
Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO 28 Jul 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 156m intellectual property
Latham & Watkins Advises Remix Therapeutics in Merger With Passage Bio 30 Jun 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP intellectual property matters
Latham & Watkins Advises Boundless Bio on Merger With Serapha Bio 24 Jun 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 230m intellectual property
Latham Advises Mineralys Therapeutics in Unique Three-Pronged Transaction — Royalty Repurchase, Debt Financing, and Equity Offering — Totaling Up to US$950 Million 8 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 950m intellectual property
Latham & Watkins Advises SPR Therapeutics in US$650 Acquisition by Medtronic 25 May 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 650m intellectual property
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Patrick Chew is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 24 deals for Patrick Chew

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction